FR3697M - Médicaments a base de nouveaux composés hétérocycliques pour le traitement des maladies des arteres coronaires. - Google Patents

Médicaments a base de nouveaux composés hétérocycliques pour le traitement des maladies des arteres coronaires.

Info

Publication number
FR3697M
FR3697M FR948214A FR948214A FR3697M FR 3697 M FR3697 M FR 3697M FR 948214 A FR948214 A FR 948214A FR 948214 A FR948214 A FR 948214A FR 3697 M FR3697 M FR 3697M
Authority
FR
France
Prior art keywords
treatment
coronary artery
heterocyclic compounds
artery disease
novel heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR948214A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR939005A external-priority patent/FR1532210A/fr
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to FR948214A priority Critical patent/FR3697M/fr
Application granted granted Critical
Publication of FR3697M publication Critical patent/FR3697M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR948214A 1963-05-27 1963-09-20 Médicaments a base de nouveaux composés hétérocycliques pour le traitement des maladies des arteres coronaires. Expired FR3697M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR948214A FR3697M (fr) 1963-05-27 1963-09-20 Médicaments a base de nouveaux composés hétérocycliques pour le traitement des maladies des arteres coronaires.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2392863 1963-05-27
FR939005A FR1532210A (fr) 1963-06-21 1963-06-21 Composés hétérocycliques et leur procédé de préparation
FR948214A FR3697M (fr) 1963-05-27 1963-09-20 Médicaments a base de nouveaux composés hétérocycliques pour le traitement des maladies des arteres coronaires.

Publications (1)

Publication Number Publication Date
FR3697M true FR3697M (fr) 1965-11-22

Family

ID=10203573

Family Applications (1)

Application Number Title Priority Date Filing Date
FR948214A Expired FR3697M (fr) 1963-05-27 1963-09-20 Médicaments a base de nouveaux composés hétérocycliques pour le traitement des maladies des arteres coronaires.

Country Status (1)

Country Link
FR (1) FR3697M (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494584A1 (fr) * 1980-11-24 1982-05-28 Ferrer Int Medicaments constitues par de nouveaux 2-aminoethanols et leur procede de fabrication
EP0266558A2 (fr) * 1986-10-07 1988-05-11 Roche Diagnostics GmbH 5-Alkylbenzimidazoles, leur procédé de préparation et médicaments les contenant
EP0325802A1 (fr) * 1988-01-05 1989-08-02 Bayer Ag Application de dérivés de benzimidazole comme promoteur de performance

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494584A1 (fr) * 1980-11-24 1982-05-28 Ferrer Int Medicaments constitues par de nouveaux 2-aminoethanols et leur procede de fabrication
EP0266558A2 (fr) * 1986-10-07 1988-05-11 Roche Diagnostics GmbH 5-Alkylbenzimidazoles, leur procédé de préparation et médicaments les contenant
EP0266558A3 (fr) * 1986-10-07 1989-08-09 Roche Diagnostics GmbH 5-Alkylbenzimidazoles, leur procédé de préparation et médicaments les contenant
EP0325802A1 (fr) * 1988-01-05 1989-08-02 Bayer Ag Application de dérivés de benzimidazole comme promoteur de performance

Similar Documents

Publication Publication Date Title
FR3806M (fr) Médicament a base d'un dérivé de la quinazolone-(4).
FR1390509A (fr) Production de 1. 4-cis-polydiènes par polymérisation de 1. 3-diènes
FI45970C (fi) Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi.
FR3681M (fr) Médicament a base de composés hétérocycliques.
FR2984M (fr) Médicament pour le traitement de troubles cardiovasculaires a base de dl-4-(acéthyl-aminométhyl)-1-[2-(1,4-benzodioxanyl)-méthyl]-4-phénylpipéridine.
FR3010M (fr) Nouveaux médicaments dérivés du benzene pour le traitement des maladies cardiaques.
FR2583M (fr) Nouveaux 2-[2-(5-nitrofuryl)-vinyl]-azoles pour le traitement des infections.
FR2489M (fr) Médicament pour le traitement de la dysenterie amibienne.
FR3697M (fr) Médicaments a base de nouveaux composés hétérocycliques pour le traitement des maladies des arteres coronaires.
FR2243M (fr) Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur.
FR2944M (fr) Médicament pour le traitement de la toux a base de 2-amino-6-méthylheptane.
FR3672M (fr) Médicament a base de dérivés de l'acide nicotinique pour le traitement d'affections circulatoires.
OA00939A (fr) Procédé pour la préparation d'amino-isoxazoles.
FR3077M (fr) Médicaments nouveaux a base de dérivés benzéniques pour le traitement de maladies des arteres coronaires.
FR1130M (fr) Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales.
FR3153M (fr) Médicament pour le traitement des affections des coronaires, a base d'isopropylidene-2',3' adénosine.
FR3064M (fr) Médicaments a base de composés aryl-thio-aliphatiques pour le traitement de l'athérosclérose.
FR2193M (fr) Nouveau médicament pour le traitement des maladies infectieuses.
FR1967M (fr) Médicaments a base de dérivés du 1,3,4,-thiadiazole pour le traitement de l'épilepsie.
OA02022A (fr) Procédé de préparation de nouvelles benzène-sulfonylurées.
FR2786M (fr) Médicament pour le traitement des maladies cardiaques.
FR1904M (fr) Médicament a base d'acide n-acyl-hydroxyamino-acétique pour le traitement des tumeurs.
FR3606M (fr) Pommade a base d'un dérivé de la cortisone pour le traitement des maladies de la peau.
FR2147M (fr) Médicament pour le traitement des différents syndromes de la sénescence.
FR2940M (fr) Médicament pour le traitement des artériopathies a base d'acide glyoxylique.